In recent years, India’s pharmaceutical landscape has witnessed a significant transformation. Beyond being the “pharmacy of the world” for affordable medicines, India is emerging as a preferred global...
Relevant Global and Market Data India’s biopharmaceutical export story is one of remarkable transformation. From being a net importer of medicines in the late 20th century to becoming the “...
Latest Developments on API Self-Reliance India has long been recognized as the “pharmacy of the world,” supplying affordable generic medicines to countries across the globe. However, despite its...
Recent Industry Context Clinical trials have always been a crucial pillar of healthcare innovation, acting as the bridge between breakthrough science and real-world patient benefit. In recent ye...
Key Highlights: Implications: Oncology ace Vanneste turbocharges MSD’s immuno-oncology push against Roche/Pfizer, targeting India’s exploding cancer caseload with ke...
Key Highlights: Implication: This divestment signals multinational pharma firms accelerating exits from legacy India operations, potentially pressuring peers like Roche and Sanofi to restructure...
Emerging Technology Trends in Biopharma The intersection of technology and biopharma isn’t a futuristic idea anymore it’s happening right now. Artificial intelligence (...
Key Highlights: Implications: Lilly’s India manufacturing bet locks in low-cost production muscle, outflanking China-dependent rivals as Mounjaro mania drives capacit...
Key Highlights: Implications: Sanofi’s Hyderabad bet signals all-in pharma offshoring, vacuuming up AI/data talent that smaller players can’t touch while crushi...
Key Highlights: Implications: India’s GATINN catapults Servier into SPC dominance, crushing fragmented chronic therapy rivals while exploding patient compliance across emerging marke...
